Article
Extracellular Matrix as a Target in Melanoma Therapy: From Hypothesis to Clinical Trials
19 Nov 2024
Abstract excerpt
Melanoma is a malignant, highly metastatic neoplasm showing increasing morbidity and mortality. Tumor invasion and angiogenesis are based on remodeling of the extracellular matrix (ECM). Selective inhibition of functional components of cell-ECM interaction, such as hyaluronic acid (HA), matrix metalloproteinases (MMPs), and integrins, may inhibit tumor progression and enhance the efficacy of combination treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
